Securities Registration: Employee Benefit Plan (s-8)
June 22 2023 - 4:19PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on June 22, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CHROMADEX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
|
26-2940963 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
10900 Wilshire Blvd., Suite 600
Los Angeles, California 90024
(310) 388-6706
(Address, including zip code, and telephone number, including area
code, of registrant’s principal executive offices)
ChromaDex Corporation 2017 Equity Incentive
Plan
(Full title of the plan)
Robert Fried
Chief Executive Officer
10900 Wilshire Blvd., Suite 600
Los Angeles, California 90024
(310) 388-6706
(Name, address, including zip code, and telephone
number, including area code, of agent for service)
Copies to:
Ben Orlanski, Esq.
Louis Rambo, Esq.
Proskauer Rose LLP
2029 Century Park East, Suite 2400
Los Angeles, CA 90067
(310) 557-2900 |
Brianna L. Gerber
Chief Financial Officer
10900 Wilshire Boulevard, Suite 600
Los Angeles, CA 90024
(310) 388-6706 |
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
Emerging growth company ☐ |
|
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is
filed pursuant to General Instruction E to Form S-8 by ChromaDex Corporation (the “Company”) for the purpose of registering
an additional 3,650,000 shares of the Company’s common stock, par value $0.001 per share (“common stock”), that
were added to the ChromaDex Corporation 2017 Equity Incentive Plan, as amended (the “2017 Plan”), pursuant to a share reserve
increase approved by the Company’s stockholders on June 15, 2023. The Company previously registered shares of its common stock
for issuance under the 2017 Plan on Registration Statements on Form S-8 filed with the Securities and Exchange Commission (the “SEC”)
on October 31, 2017 (File No. 333-221246), March 23, 2018 (File No. 333-223889), August 22, 2018 (File No. 333-226972) and August 18,
2020 (File No. 333-248104) (the “Prior Registration Statements”). Pursuant to General Instruction E to Form S-8, this
Registration Statement hereby incorporates by reference the contents of the Prior Registration Statements.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. | INCORPORATION
OF DOCUMENTS BY REFERENCE |
The following documents filed
by the Company with the SEC are incorporated by reference into this Registration Statement:
| a) | The Company’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2022, filed with the SEC on March 8, 2023 (including the portions of the Company’s definitive proxy statement
on Schedule 14A filed on April 28, 2023 incorporated by reference therein); |
| b) | The Company’s Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2023, filed with the SEC on May 10, 2023; |
| d) | The description of the Company’s common stock included
in the Company’s Form 8-A filed with the SEC on April 21, 2016, including any amendments or reports filed for the purpose of updating
such description. |
In addition, all of the Company’s
reports filed with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), after the date of this Registration Statement and prior to filing a post-effective amendment that indicates that all securities
offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference
in this Registration Statement and to be a part hereof from the date of filing of such reports.
Any statement contained herein
or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes
of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is or is deemed to
be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Registration Statement.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Los Angeles, State of California, on June 22, 2023.
|
CHROMADEX CORPORATION |
|
|
|
|
By: |
/s/ Robert Fried |
|
|
Robert Fried |
|
|
Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose
signature appears below constitutes and appoints Robert Fried and Brianna L. Gerber, and each of them, as his or her true and lawful attorneys-in-fact
and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities,
to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits
thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done
in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
ROBERT FRIED
|
|
Chief Executive Officer and Director |
|
June 22, 2023 |
Robert Fried |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/
BRIANNA L. GERBER
|
|
Chief Financial Officer |
|
June 22, 2023 |
Brianna L. Gerber |
|
(Principal Financial and Accounting Officer) |
|
|
|
|
|
|
|
/s/ FRANK L. JAKSCH JR. |
|
Director |
|
June 22, 2023 |
Frank L. Jaksch Jr. |
|
|
|
|
|
|
|
|
|
/s/ GARTY NG |
|
Director |
|
June 22, 2023 |
Gary Ng |
|
|
|
|
|
|
|
|
|
/s/ STEVEN D. RUBIN |
|
Director |
|
June 22, 2023 |
Steven D. Rubin |
|
|
|
|
|
|
|
|
|
/s/ WENDY YU |
|
Director |
|
June 22, 2023 |
Wendy Yu |
|
|
|
|
|
|
|
|
|
/s/ KRISTIN PATRICK |
|
Director |
|
June 22, 2023 |
Kristin Patrick |
|
|
|
|
/s/ ANN COHEN
|
|
Director |
|
June 22, 2023 |
Ann Cohen |
|
|
|
|
|
|
|
|
|
/s/ HAMED SHAHBAZI |
|
Director |
|
June 22, 2023 |
Hamed Shahbazi |
|
|
|
|
4
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Jun 2024 to Jul 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Jul 2023 to Jul 2024